A Real-world Study of Durvalumab for Lung Cancer in China

Clinical trial NCT04672759 · UNKNOWN

Trial details

NCT number: NCT04672759
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer Stage III Small-Cell Lung Cancer

Start date: 2020-07-28
Primary completion: 2021-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.